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Abstract
To assess the role of non-tuberculous mycobacteria (NTM) as a cause of tuberculosis-like diseases in Zambia, 167 chronically ill
patients, hospitalized in three rural hospitals in Katete, Sesheke and Chilonga, were examined by microscopy and liquid culture for the
presence of NTM. The percentages of patients with a positive culture for Mycobacterium tuberculosis complex were similar in the three
geographical locations (19–25%). In contrast, the percentage of NTM ranged from 78% in Katete and 65% in Sesheke to 21% in Chilon-
ga. Furthermore, the distribution of NTM species was different at the three geographical sites. In seven patients, true NTM-associated
disease was suspected: ﬁve with Mycobacterium lentiﬂavum and two with Mycobacterium intracellulare. Analysis of possible risk factors indi-
cated that the OR for NTM culture-positive sputum was signiﬁcantly higher for patients living in Katete and Sesheke. Female gender
and chest X-ray appearances of tuberculosis were independently associated with NTM culture-positive sputum. NTM colonization and
disease in hospitalized, chronically ill patients in rural Zambia appear to be common.
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Introduction
Tuberculosis (TB) is nearly always caused by Mycobacterium
tuberculosis. However, non-tuberculous mycobacteria (NTM)
can also mimic this disease. Large geographical variation in
the distribution of NTM has been reported worldwide. In
the USA, NTM-associated lung disease is most commonly
attributed to Mycobacterium avium complex (MAC), with
Mycobacterium kansasii being the second most important
causative agent [1]. In the UK, especially in England and
Wales, M. kansasii is the pathogen most commonly associ-
ated with NTM-associated lung disease, whereas Mycobacte-
rium malmoense is most commonly encountered in Scotland,
and Mycobacterium xenopi predominates in southeastern
England [2]. In Japan, the most common cause of NTM-
associated lung disease is MAC, followed by M. kansasii [3].
However, in most parts of the world, especially in those
areas with a high prevalence of TB, the distribution of NTM
in clinical isolates is not known.
Reported rates of NTM colonization and disease are
probably underestimates. Colonization rates are especially
uncertain, as people without signiﬁcant symptoms will not
commonly undergo the intensive investigations needed to
detect NTM. This is compounded by the lack of systematic
reporting of NTM isolation in most countries.
In African countries, despite the fact that environmental
exposure to NTM is very high, NTM colonization and dis-
ease are hardly reported, even among patients with AIDS
[4]. However, it is not clear whether this is due to a truly
low prevalence of NTM disease or whether the magnitude
of this problem has not yet been revealed. A number of
studies on the epidemiology of NTM have, however, been
performed in South Africa. In two population-based studies,
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rates of NTM colonization were 1400 and 6700 per
100 000, respectively [5,6]. Two other studies on NTM in
this country focused on a population of gold-miners [7,8]:
the annual rate of NTM disease in this group was found to
be 101 per 100 000, with the two most common organisms
isolated being M. kansasii (66/100 000) and Mycobacterium
scrofulaceum (12/100 000).
In recent years, the clinical importance of NTM has
become increrasingly recognized [9]. The set of criteria in a
Statement of the American Thoracic Society (ATS) in 1997,
revised in 2007, can be used to differentiate between true
NTM disease, colonization, pseudo-infection, and contamina-
tion [2,10,11]. This differentiation is made on the basis of
clinical, radiological and microbiological features.
The goal of this pilot study was to assess the role of
NTM in TB-like diseases in various rural settings in Zambia.
Materials and Methods
One hundred and sixty-seven chronically ill adult patients,
hospitalized in three rural hospitals in different provinces of
Zambia from March to August 2001, were the subjects of
this study. These hospitals were St Francis Hospital in Katete
(Eastern Province), Yeta District Hospital in Sesheke (Wes-
tern Province), and Our Lady’s Hospital in Chilonga (North-
ern Province). All patients above the age of 15 years, with
symptoms in any part of the body for more than 2 weeks,
were included.
Sputa of the patients were examined for presence of acid-
fast bacteria and subjected to culture in Mycobacteria
Growth Indicator Tubes (Becton Dickinson Microbiology
Systems, Cockeysville, MD, USA). Decontamination of spu-
tum samples was performed using N-acetyl-L-cysteine–NaOH
and sulphuric acid, as described previously [12]. In Katete
and Sesheke, the sputum was collected twice on two consec-
utive days. In Chilonga, a single sputum sample was collected
and cultured, for logistic reasons. Serological testing for
human immunodeﬁciency virus (HIV) was performed using a
qualitative immunoassay (Abbott Determine HIV-1/2) and
the Vidas HIV DUO assay (BioMe´rieux, Marcy l’Etoile,
France). Chest X-rays were evaluated in a blinded manner in
The Netherlands. The Accuprobe culture conﬁrmation test
for M. tuberculosis complex (Accuprobe; BioMe´rieux) and/or
16S rRNA gene sequencing were used to identify Mycobacte-
rium isolates [13].
Data analysis
Data were entered into SPSS 6 and analysed using STATA
v. 8.0 (Stata Corporation, College Station, TX, USA). Stu-
dent’s t-test was used to compare means between groups,
and the chi-square test to compare proportions. Univariate
ORs with 95% CIs were calculated to assess associations of
risk factors for NTM isolation. A stepwise backward regres-
sion approach was used for multivariate analysis.
Results
General characteristics
A total of 167 chronically ill patients were included in the
study; 63 in Katete, 51 in Sesheke, and 53 in Chilonga. The
patient characteristics are shown in Table 1. The proportion
of HIV-positive patients varied between 69% and 79% in the
three hospitals. The occupation of the majority of patients in
Katete and Sesheke was farming: 71% and 61%, respectively.
In Chilonga, more variation was observed. In Katete, most
patients (52%) retrieved their water from a borehole. In
Sesheke and Chilonga, the main source of water was a river
in combination with tap water (40–45%). Patients who were
TABLE 1. Characteristics of included patients with chronic complaints for at least 2 weeks in Katete, Sesheke, and Chilonga
Katete Sesheke Chilonga p-value All
Number of included patients, n (%)63 51 53 167
Female, n (%) 37 (59) 26 (51) 19 (36) 0.05 82 (49)
Age (years), median (range) 36 (18–76) 37 (18–67) 39 (15–74) 0.9 38 (7–76)
HIV, n (%) 48 (79) 38 (76) 34 (69) 0.3 120 (75)
Farmer, n (%) 45 (71) 31 (61) 19 (36) <0.001 95 (57)
Smoking, n (%) 1 (2) 11 (22) –a 0.001 12 (11)
Using alcohol, n (%) 4 (7) 15 (31) –a 0.01 19 (18)
Tuberculosis treatment in the past, n (%) 12 (19) 15 (29) 15 (28) 0.4 42 (25)
Water source, n (%)
Well 16/60 (27) 7 (14) 5/39 (13) 29 (19)
Borehole 31/60 (52) 0 2/39 (5) 33 (22)
Tap 5/60 (8) 21 (41) 15/39 (40) 41 (27)
River 8/60 (13) 23 (45) 16/39 (42) <0.001 47 (31)
Unboiled milk, n (%) 1 (2) 35 (69) –a <0.001 36 (33)
Died during study period, n (%) 9 (14) 1 (2) 5 (9) 0.07 15 (9)
HIV, human immunodeﬁciency virus.
aData on smoking and using alcohol or (un)boiled milk were not available in Chilonga.
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milk consumers in Katete usually boiled their milk prior to
use. The patients in Sesheke mainly used unboiled milk. Most
of the 167 patients complained of regular coughing and/or
chest pain (79%). Complaints of the digestive tract were
found in 13% of the patients, and the other 8% of patients
had either skin infections/abscesses, enlarged lymph nodes,
or complaints of the urogenital tract or central nervous
system.
Culture results
The percentages of patients with a positive culture for
M. tuberculosis complex were almost equal in the three loca-
tions, and varied between 19% and 25% (Table 2). The num-
ber of patients with positive NTM cultures was signiﬁcantly
higher in Katete (78%) and Sesheke (65%) than in Chilonga
(21%). However, in Chilonga, only one sputum specimen was
cultured per patient, unlike in Katete and Sesheke. Neverthe-
less, taking only the ﬁrst sputum specimen in Katete and Ses-
heke into account, the number of patients with positive
NTM cultures was still signiﬁcantly higher in Katete and Ses-
heke than in Chilonga. The sputum smear was positive in 19
of 38 patients (50%) with sputum culture positive for
M. tuberculosis complex and in only three of 76 (4%) patients
with sputum culture positive for only NTM.
In all three hospitals, the sputum specimens were split
into two equal parts before decontamination and culturing.
In Katete, 217 (split) sputum specimens were cultured from
63 patients (Table 3). Therefore, 109 (217/2) sputum speci-
mens were collected in Katete, in 92 (184/2) in Sesheke, and
52 (103/2) in Chilonga. Mycobacteria were isolated from 140
of the 217 (65%) sputum specimens collected in Katete;
M. tuberculosis was found in 16 of the 217 (7%) cultured spu-
tum specimens, and NTM in 124 (57%). The most commonly
isolated NTM were Mycobacterium lentiﬂavum (42) and Myco-
bacterium intracellulare (19). The number of mycobacteria iso-
lated in Sesheke was similar to the number isolated in Katete.
In contrast, no M. lentiﬂavum was found in Sesheke. In Chilon-
ga, usually only one sputum specimen was collected per
patient, and this was also divided and pretreated in two ways
before culturing. There were 103 sputum specimens cultured
from 53 patients but, in contrast to Katete and Sesheke, only
36 (35%) cultures were positive for mycobacteria. M. tubercu-
losis was found in 18 of the 103 (17%) cultured sputum speci-
mens and NTM in the other 18 (17%). M. intracellulare and
M. lentiﬂavum were not isolated in Chilonga.
Comparison of patients with and without NTM in their
sputum
The demographic and clinical characteristics of patients with
positive and negative NTM cultures were analysed. The med-
ical history, physical examination and chest X-ray pathology
did not show signiﬁcant differences (Table 4). Table 5 shows
the analysis of possible risk factors for patients with NTM in
their sputum. The OR for NTM culture-positive sputum was
signiﬁcantly higher for patients living in Katete and Sesheke.
Furthermore, female gender and suspicion of TB on chest
X-ray were independently associated with NTM culture-posi-
tive sputum. A higher OR (although not signiﬁcant in the
multivariate analysis) was associated with farming and using
TABLE 3. Mycobacteria isolated from sputum specimens in
Katete, Sesheke, and Chilonga
Culture result
Isolates
in Katete,
n (%)
Isolates in
Sesheke,
n (%)
Isolates
in Chilonga,
n (%)
Negative 77 (35) 55 (30) 67 (65)
Mycobacterium tuberculosis 16 (7) 25 (14) 18 (17)
Mycobacterium avium complex
Mycobacterium intracellulare 19 (9) 19 (10) 0
M. avium 0 0 1 (1)
Mycobacterium chelonae 8 (4) 0 0
Mycobacterium lentiﬂavum 42 (19) 0 0
Various unknown Mycobacterium
species
18 (8) 29 (16) 5 (5)
Various other Mycobacterium speciesa 7 (3) 14 (8) 6 (6)
AFB without identiﬁcation 30 (14) 42 (23) 6 (6)
Total number of split sputum
specimens
217 184 103
AFB acid-fast bacilli.
aVarious other Mycobacterium species in Katete included Mycobacterium mucogen-
icum, Mycobacterium elephantis, Mycobacterium gordonae, Mycobacterium gilvum and
Mycobacterium rhodesia. Various other Mycobacterium species in Sesheke included
Mycobacterium fortuitum, M. mucogenicum, Mycobacterium asiaticum, Mycobacterium
terrae and Mycobacterium triplex. Various other Mycobacterium species in Chilonga
included M. mucogenicum, M. triplex, Mycobacterium obuense and M. gordonae.
TABLE 2. Patients with positive Mycobacterium cultures in Katete, Sesheke, and Chilonga
Katete, n (%) Sesheke, n (%) Chilonga, n (%) p-value All, n (%)
Number of included patients 63 51 53 167
Mycobacterium tuberculosis complex 12 (19) 13 (25) 13 (25) 0.7 38 (23)
NTM in any sputum specimen 49 (78) 33 (65) 11 (21) <0.001 93 (56)
NTM in only ﬁrst sputum specimen 42 (67) 25 (49) 11 (21) <0.001 78 (45)
NTM in ﬁrst and second sputum specimens 28 (44) 12 (24) –a 0.02 40 (35)
Same NTM in both sputa 13 (21) 5 (10) –a 0.1 18 (16)
NTM and M. tuberculosis 8 (13) 7 (14) 3 (6) 18 (10)
NTM, non-tuberculous mycobacteria.
aOnly a single sputum specimen per patient was cultured in Chilonga.
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water from the borehole. HIV status and the inﬂuence of
unboiled milk were not statistically signiﬁcant.
Repeated isolation of NTM from sputum
The diagnostic criteria for NTM-associated lung disease
according to the ATS include repeated isolation of the same
species Mycobacterium from sputum samples in symptomatic
patients together with imaging ﬁndings consistent with lung
disease. In this study, two sputum specimens were collected
and cultured from a total of 101 patients. M. tuberculosis was
isolated from at least one sputum specimen in 21 (21%) of
these patients, and NTM in 66 (65%). In ten patients, both
M. tuberculosis and NTM were isolated.
In 56 patients (55%), NTM alone were found in both spu-
tum specimens. In 15 of these 56 patients (15%) the same
NTM species was found in both specimens (Table 6); in 29,
NTM could not be identiﬁed in at least one sputum speci-
men, and in the remaining 12, different NTM species were
isolated. In three more patients, the same species of NTM
was found in both sputum samples, together with M. tubercu-
losis (Table 6).
A chest X-ray was performed in ten of the 15 cases with
identical NTM in both sputum specimens, and in four of
these the pathology on the chest X-ray suggested TB.
M. lentiﬂavum was isolated in both sputum samples from all
four patients. The sputum smears were positive in two
patients. In six patients, the chest X-ray showed no signs of
TB. Unfortunately, no chest X-ray was performed in ﬁve
patients. In one patient, M. lentiﬂavum was cultured from a
lymph node biopsy and from two sputum samples. In three
of these ﬁve patients, M. intracellulare was identiﬁed in both
sputum specimens. In the last patient without an X-ray,
mycobacteria were cultured from both sputum specimens
but could not be identiﬁed to species level.
Discussion
A high percentage (56%) of patients presenting with mainly
coughing and/or chest pain at three African hospitals
yielded positive NTM sputum cultures. This ﬁnding may be
due to the extremely high rate of HIV-positivity (between
69% and 79%) among the patients examined. However,
because the group of HIV-negative patients was relatively
small in this study, correlations between NTM isolation and
HIV status could not be studied adequately. The proportion
of patients with positive NTM cultures was signiﬁcantly
higher in Katete (78%) and Sesheke (65%) than in Chilonga
(21%). In Katete and Sesheke, more patients were working
as farmers than in Chilonga. Farming has not been men-
tioned in the literature as a risk factor for NTM infections,
but this is probable, as farmers have intensive exposure to
NTM in soil, water, and other environmental sources. Food
and water are also sources of human exposure to NTM
[14]. There were were differences between the villages in
their water supply and consumption of unboiled milk. This
suggests that direct contact with the environment may be a
risk factor for NTM colonization in Zambia. Other studies
have also described a patient group of elderly women with
TABLE 4. Medical history, physical examination and chest
X-ray of non-tuberculous mycobacteria (NTM) culture-posi-
tive and culture-negative patients
NTM-
positive
NTM-
negative p-value All
Number of patients 93 74 – 167
Female sex, n (%) 55 (59) 27 (36) 0.004 82 (49)
Age (years), median (range) 37 (17–76) 38 (15–74) 0.9 38 (15–76)
HIV-positive, n (%) 71 (79) 49 (70) 0.2 120 (75)
BMI, mean 17.3 17.7 0.6 17.5
Weakness, n (%) 75 (82) 63 (88) 0.3 138 (84)
Vomiting, n (%) 19 (21) 18 (25) 0.5 37 (23)
Diarrhoea, n (%) 20 (22) 15 (21) 0.9 35 (22)
Dysuria, n (%) 10 (11) 13 (18) 0.2 23 (14)
Hepatomegaly, n (%) 19 (22) 13 (22) 0.9 32 (220)
Splenomegaly, n (%) 21 (24) 10 (17) 0.3 31 (21)
Lymph nodes, n (%) 52 (56) 44 (60) 0.6 96 (58)
Chest X-ray compatible with
TB in the absence of
Mycobacterium tuberculosis in
culture, n (%)
25 (47) 15 (32) 0.1 40 (40)
Previous TB treatment, n (%) 23 (25) 19 (26) 0.9 42 (25)
Died, n (%) 8 (9) 7 (9) 0.8 15 (9)
BMI, body mass index; HIV, human immunodeﬁciency virus; TB, tuberculosis.
TABLE 5. Risk factors for positive non-tuberculous myco-
bacteria cultures from sputum
Univariate
analysis,
OR (95% CI)
Multivariate
analysis,
OR (95% CI)
Location
Chilonga 1 1
Sesheke 7.0 (2.9–16.8) 4.7 (1.6–13.7)
Katete 13.4 (5.5–32.6) 11.8 (4.5–30.8)
Sex (female) 2.5 (1.5–4.3) 2.0 (1.0–4.5)
Chest X-ray suggesting TB 1.9 (1.0–3.9) 2.5 (1.1–5.9)
Age ‡25 years 0.8 (0.3–2.1) NS
Farmer 2.0 (1.1–3.8) NS
Water (in comparison
with tap water = 1)
Borehole 3.1 (1.2–8.2) NS
Well 2.6 (0.9–7.0)
River 1.2 (0.5–2.8)
Unboiled milk 1.0 (0.4–2.4) NS
Smoking 0.4 (0.1–1.3) NS
Using alcohol 0.7 (0.2–1.9) NS
Mycobacterium tuberculosis
isolated from sputum
0.6 (0.3–1.2) NS
Tuberculosis treatment
in the past
1.0 (0.5–1.9) NS
HIV-positive 1.6 (0.8–3.3) NS
Underweight (BMI < 18) 1.0 (0.5–2.1) NS
BMI, body mass index; HIV, human immunodeﬁciency virus; NS, not (statisti-
cally) signiﬁcant; TB, tuberculosis.
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no pre-existing lung disease at increased risk of NTM colo-
nization, especially with MAC and M. kansasii [1,15]. In the
present study, female gender was also a risk factor for
NTM culture-positive sputum.
Little is known about the prevalence of different NTM in
Africa. In this study, clear geographical differences between
isolated NTM species were observed; however, the study
group was small, and the NTM isolation was restricted to
one season. Interestingly, unidentiﬁable mycobacteria were
found in all three villages (between 5% and 16% of the cul-
tured sputum specimens). These data may indicate that there
is a different distribution of mycobacteria in Africa than in
the USA and Europe, but this needs to be conﬁrmed in lar-
ger studies.
Chronic respiratory symptoms not responding to antibiot-
ics, radiological features suggesting TB and also two positive
sputum cultures fulﬁl the ATS diagnostic criteria. In this
study, 15 patients had the same NTM species in both sputum
specimens, suggesting that NTM isolation may be clinically
relevant in this group. Chest X-rays were performed in ten
of these 15 patients, and had the appearance of TB in four
patients with repeated M. lentiﬂavum sputum isolates. In at
least three of the ﬁve patients without a chest X-ray, there
was a suspicion of NTM lung disease. In one patient, M. lent-
iﬂavum was isolated from two sputum specimens and from a
(normally sterile) lymph node. In two other patients with
chronic respiratory complaints and no response to antibiot-
ics, anti-TB treatment was started. M. intracellulare was iso-
lated from consecutive sputum specimens in both patients.
The combination of symptoms, together with the positive
cultures, is highly suggestive of NTM lung disease. However,
the sputa of these patients were not tested by molecular
methods for the possible presence of M. tuberculosis. Ziehl–
Neelsen-positive sputa should ideally have been subjected to
such a test. Furthermore, culture of sputum was performed
in Mycobacteria Growth Indicator Tubes and not on solid
medium, and quantitation of CFUs and visualization of mixed
cultures were therefore not possible. A low number of
CFUs could have been an indication of colonization by NTM.
Moreover, NTM are found ubiquitously in the environment,
and colonization by NTM may result from drinking contami-
nated water or showering with it.
Recently, M. lentiﬂavum was isolated from public water
distribution systems [16]. Isolation of the same NTM species
from two different sputum specimens collected on consecu-
tive days could therefore be a result of colonization with
NTM because of exposure to drinking water contaminated
with NTM. Disease caused by M. lentiﬂavum is difﬁcult to
treat with standard anti-TB drugs; in most cases, clarithro-
mycin is added to the treatment, but the management of this
NTM disease remains difﬁcult [17]. The improvement of a
patient (no. 3) in our study on anti-TB treatment without
clarithromycin therefore suggests disease caused by M. tuber-
culosis rather than by M. lentiﬂavum.
Overall, for almost half (7/15) of the patients with the
same NTM species in both sputum specimens, there was a
basis for suspicion of NTM disease according to the criteria
of the ATS. M. lentiﬂavum was isolated twice in ﬁve patients,
and M. intracellulare was isolated twice in two patients. In this
study, the estimated rate of colonization was 58% (59/101),
with a striking rate of disease of about 7% (7/101). The fact
that all patients presented at the hospitals with chronic com-
plaints could partially explain such a high rate.
Laboratory cross-contamination is considered to be highly
unlikely in this study, for the following reasons. The same
methods were used at all three villages; the mycobacterial
isolates represented several evolutionary lineages and strain
variations [18]; and, in a signiﬁcant proportion of the cases,
the same NTM were isolated from consecutive sputa, indi-
cating that the quality of NTM isolation was adequate.
We conclude, therefore, that NTM colonization and infec-
tion are common in rural Zambia and deserve further study.
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